BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7803763)

  • 1. Regulation and functions of the glycogen synthase kinase-3 subfamily.
    Woodgett JR
    Semin Cancer Biol; 1994 Aug; 5(4):269-75. PubMed ID: 7803763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Judging a protein by more than its name: GSK-3.
    Woodgett JR
    Sci STKE; 2001 Sep; 2001(100):re12. PubMed ID: 11579232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear glycogen and glycogen synthase kinase 3.
    Ragano-Caracciolo M; Berlin WK; Miller MW; Hanover JA
    Biochem Biophys Res Commun; 1998 Aug; 249(2):422-7. PubMed ID: 9712712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
    Hoeflich KP; Luo J; Rubie EA; Tsao MS; Jin O; Woodgett JR
    Nature; 2000 Jul; 406(6791):86-90. PubMed ID: 10894547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.
    Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of glucose and the hexosamine biosynthesis pathway on glycogen synthase kinase-3 and other protein kinases that regulate glycogen synthase activity.
    Singh LP; Crook ED
    J Investig Med; 2000 Jul; 48(4):251-8. PubMed ID: 10916283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions.
    Levy-Strumpf N; Kimchi A
    Oncogene; 1998 Dec; 17(25):3331-40. PubMed ID: 9916995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renaissance of GSK3.
    Cohen P; Frame S
    Nat Rev Mol Cell Biol; 2001 Oct; 2(10):769-76. PubMed ID: 11584304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of brain proteins in glycogen synthase kinase-3 transgenic mice: a proteomics point of view.
    Tilleman K; Stevens I; Spittaels K; Haute CV; Clerens S; Van Den Bergh G; Geerts H; Van Leuven F; Vandesande F; Moens L
    Proteomics; 2002 Jan; 2(1):94-104. PubMed ID: 11788996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2.
    Hartigan JA; Xiong WC; Johnson GV
    Biochem Biophys Res Commun; 2001 Jun; 284(2):485-9. PubMed ID: 11394906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
    Martinez A; Castro A; Dorronsoro I; Alonso M
    Med Res Rev; 2002 Jul; 22(4):373-84. PubMed ID: 12111750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin decreases the glycogen synthase kinase-3 alpha mRNA levels by altering its stability in streptozotocin-induced diabetic rat liver.
    Rao PV; Pugazhenthi S; Khandelwal RL
    Biochem Biophys Res Commun; 1995 Dec; 217(1):250-6. PubMed ID: 8526919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assay for glycogen synthase kinase 3 (GSK-3) for use in crude cell extracts.
    Ryves WJ; Fryer L; Dale T; Harwood AJ
    Anal Biochem; 1998 Nov; 264(1):124-7. PubMed ID: 9784196
    [No Abstract]   [Full Text] [Related]  

  • 14. Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C.
    Cook D; Fry MJ; Hughes K; Sumathipala R; Woodgett JR; Dale TC
    EMBO J; 1996 Sep; 15(17):4526-36. PubMed ID: 8887544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
    Cross DA; Alessi DR; Cohen P; Andjelkovich M; Hemmings BA
    Nature; 1995 Dec 21-28; 378(6559):785-9. PubMed ID: 8524413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GSK3, a master switch regulating cell-fate specification and tumorigenesis.
    Kim L; Kimmel AR
    Curr Opin Genet Dev; 2000 Oct; 10(5):508-14. PubMed ID: 10980428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GSK3 beta signaling cascade and neurodegenerative disease.
    Kaytor MD; Orr HT
    Curr Opin Neurobiol; 2002 Jun; 12(3):275-8. PubMed ID: 12049933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase and Dictyostelium development: old pathways pointing in new directions?
    Insall R
    Trends Genet; 1995 Feb; 11(2):37-9. PubMed ID: 7716803
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycogen synthase kinase-3: properties, functions, and regulation.
    Ali A; Hoeflich KP; Woodgett JR
    Chem Rev; 2001 Aug; 101(8):2527-40. PubMed ID: 11749387
    [No Abstract]   [Full Text] [Related]  

  • 20. Glycogen synthase kinase-3: functions in oncogenesis and development.
    Plyte SE; Hughes K; Nikolakaki E; Pulverer BJ; Woodgett JR
    Biochim Biophys Acta; 1992 Dec; 1114(2-3):147-62. PubMed ID: 1333807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.